Your browser doesn't support javascript.
loading
Prospective Isolation of Poised iPSC Intermediates Reveals Principles of Cellular Reprogramming.
Schwarz, Benjamin A; Cetinbas, Murat; Clement, Kendell; Walsh, Ryan M; Cheloufi, Sihem; Gu, Hongcang; Langkabel, Jan; Kamiya, Akihide; Schorle, Hubert; Meissner, Alexander; Sadreyev, Ruslan I; Hochedlinger, Konrad.
Afiliación
  • Schwarz BA; Department of Molecular Biology, Cancer Center, and Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harva
  • Cetinbas M; Department of Molecular Biology, Cancer Center, and Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
  • Clement K; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Walsh RM; Department of Molecular Biology, Cancer Center, and Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harva
  • Cheloufi S; Department of Molecular Biology, Cancer Center, and Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harva
  • Gu H; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Langkabel J; University of Bonn Medical School, Institute of Pathology, Department of Developmental Pathology, Bonn, Germany.
  • Kamiya A; Department of Molecular Life Sciences, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
  • Schorle H; University of Bonn Medical School, Institute of Pathology, Department of Developmental Pathology, Bonn, Germany.
  • Meissner A; Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Sadreyev RI; Department of Molecular Biology, Cancer Center, and Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
  • Hochedlinger K; Department of Molecular Biology, Cancer Center, and Center for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harva
Cell Stem Cell ; 23(2): 289-305.e5, 2018 Aug 02.
Article en En | MEDLINE | ID: mdl-30017590
Cellular reprogramming converts differentiated cells into induced pluripotent stem cells (iPSCs). However, this process is typically very inefficient, complicating mechanistic studies. We identified and molecularly characterized rare, early intermediates poised to reprogram with up to 95% efficiency, without perturbing additional genes or pathways, during iPSC generation from mouse embryonic fibroblasts. Analysis of these cells uncovered transcription factors (e.g., Tfap2c and Bex2) that are important for reprogramming but dispensable for pluripotency maintenance. Additionally, we observed striking patterns of chromatin hyperaccessibility at pluripotency loci, which preceded gene expression in poised intermediates. Finally, inspection of these hyperaccessible regions revealed an early wave of DNA demethylation that is uncoupled from de novo methylation of somatic regions late in reprogramming. Our study underscores the importance of investigating rare intermediates poised to produce iPSCs, provides insights into reprogramming mechanisms, and offers a valuable resource for the dissection of transcriptional and epigenetic dynamics intrinsic to cell fate change.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reprogramación Celular / Células Madre Pluripotentes Inducidas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Stem Cell Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reprogramación Celular / Células Madre Pluripotentes Inducidas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Stem Cell Año: 2018 Tipo del documento: Article